Skip to content

Clinical trials

Phase 2 Sjogren's Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sjogren's Syndrome Phase: Phase 2 Country / region: United States Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20113
20131
20141
20163
20171
20193
20202
20214
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated5
Recruiting3
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Dental and Craniofacial Research (NIDCR)6
Novartis Pharmaceuticals6
Amgen2
Arthritis & Rheumatism Associates, P.C.1
Artiva Biotherapeutics, Inc.1
Bristol-Myers Squibb1
Gilead Sciences1
Hoffmann-La Roche1
Institut de Recherches Internationales Servier1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sjogren's Syndrome29
Xerostomia9
Autoimmune Diseases8
Dry Eye Syndromes6
Arthritis3
Arthritis, Rheumatoid3
Keratoconjunctivitis Sicca3
Salivary Gland Diseases3
Xerophthalmia3
Inflammation2

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.